CN111084317A - 一种保健型固体饮料及其制备方法 - Google Patents
一种保健型固体饮料及其制备方法 Download PDFInfo
- Publication number
- CN111084317A CN111084317A CN202010144083.7A CN202010144083A CN111084317A CN 111084317 A CN111084317 A CN 111084317A CN 202010144083 A CN202010144083 A CN 202010144083A CN 111084317 A CN111084317 A CN 111084317A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- solid beverage
- health
- care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 51
- 239000007787 solid Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 72
- 240000000249 Morus alba Species 0.000 claims abstract description 36
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 36
- 239000006041 probiotic Substances 0.000 claims abstract description 17
- 235000018291 probiotics Nutrition 0.000 claims abstract description 17
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 16
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 16
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 16
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 15
- 235000006092 Stevia rebaudiana Nutrition 0.000 claims abstract description 15
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 14
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 7
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract 2
- 229920001202 Inulin Polymers 0.000 claims description 16
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 16
- 229940029339 inulin Drugs 0.000 claims description 16
- 239000001913 cellulose Substances 0.000 claims description 14
- 229920002678 cellulose Polymers 0.000 claims description 14
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 13
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 13
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 13
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 13
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 13
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 13
- 230000036541 health Effects 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 4
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 4
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 2
- 230000000529 probiotic effect Effects 0.000 claims description 2
- 239000003973 paint Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 27
- 239000008280 blood Substances 0.000 abstract description 27
- 235000000346 sugar Nutrition 0.000 abstract description 17
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 13
- 241000282414 Homo sapiens Species 0.000 abstract description 10
- 230000036039 immunity Effects 0.000 abstract description 9
- 230000035622 drinking Effects 0.000 abstract description 3
- 239000000796 flavoring agent Substances 0.000 abstract description 2
- 235000019634 flavors Nutrition 0.000 abstract description 2
- 238000012423 maintenance Methods 0.000 abstract description 2
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 239000013585 weight reducing agent Substances 0.000 abstract 1
- 241000229143 Hippophae Species 0.000 description 14
- 229940068140 lactobacillus bifidus Drugs 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 235000002722 Dioscorea batatas Nutrition 0.000 description 4
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 4
- 240000001811 Dioscorea oppositifolia Species 0.000 description 4
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000008855 peristalsis Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- WHBHBVVOGNECLV-OBQKJFGGSA-N 11-deoxycortisol Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 WHBHBVVOGNECLV-OBQKJFGGSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 230000007661 gastrointestinal function Effects 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- -1 triterpene compounds Chemical class 0.000 description 2
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- YWJXCIXBAKGUKZ-HJJNZUOJSA-N Bergenin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@H]2C3=C(O)C(OC)=C(O)C=C3C(=O)O[C@@H]21 YWJXCIXBAKGUKZ-HJJNZUOJSA-N 0.000 description 1
- XULPLJSODQQHPH-UHFFFAOYSA-N Bergenin Natural products OCC1OC2C(OC(=O)c3cc(O)c(CO)c(O)c23)C(O)C1O XULPLJSODQQHPH-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 235000021539 instant coffee Nutrition 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000020162 malted milk drink Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
Abstract
本发明提供一种保健型固体饮料及其制备方法，属于保健饮品技术领域。其中所述保健型固体饮料包括以下重量份数的组分：膳食纤维33份、益生菌33份、大豆分离蛋白10份、桑叶粉10份、沙棘粉5份、山药粉5份、桑葚粉3份、甜叶菊粉1份。本发明的固体饮料具有改善肠道、提高人体免疫力、降血糖等保健的功效，且具有质量显著减轻，体积显著变小，携带方便，风味好，速溶性好，易于保持卫生，包装简易，运输方便及冲饮方便的优点。
Description
技术领域
本发明属于保健饮品技术领域，具体涉及一种保健型固体饮料及其制备方法。
背景技术
固体饮料是指以糖、乳和乳制品、蛋或蛋制品、果汁或食用植物提取物等为主要原料，添加适量的辅料或食品添加剂制成的每100克成品水分不高于5克的固体制品，呈粉末状、颗粒状或块状，如豆晶粉、麦乳精，速溶咖啡、菊花晶等。
随着社会发展，人们的生活水平在逐步提高，在日常的餐饮中，鱼肉比例也在逐步提高，由于肉类、油脂类的大量摄入，引起胰岛素绝对或相对不足以及组织细胞对胰岛素敏感性降低而引发糖尿病，无论是发达国家还是其他国家糖尿病的发病率日超增加，已经成为威胁人类健康的主要杀手，而目前医学水平还没有达到根治糖尿病的药物，只能依靠控制饮食和各种降糖药来缓解糖尿病的病情。
但是降糖药具有毒副作用，为了解决上述问题，我们提出一种具有改善肠道、提高人体免疫力、降血糖等保健功效的固体饮料及其制备方法。
发明内容
本发明的目的在于提供一种保健型固体饮料，该固体饮料具有改善肠道、提高人体免疫力、降血糖等保健的功效；同时，本发明的目的还在于提供一种上述保健型固体饮料的制备的制备方法。
为实现上述目的，本发明一种保健型固体饮料采用的技术方案是：所述保健型固体饮料包括以下重量份数的组分：膳食纤维33份、益生菌33份、大豆分离蛋白10份、桑叶粉10份、沙棘粉5份、山药粉5份、桑葚粉3份、甜叶菊粉1份。
膳食纤维能助消化，防治便秘，防治痔疮；还能提高免疫力，平衡体内的荷尔蒙及降低与荷尔蒙相关的癌症；降低胆固醇和高血压，降低胰岛素和三酸甘油脂；有助于通便、利尿、清肠健胃。
益生菌是对人体健康有益的微生物，能维持肠道健康平衡，具有改善肠道、增强免疫等功能。
大豆分离蛋白的蛋白质含量高，含有8种氨基酸，且含量较为平衡，属于全价蛋白质，同时还含有人体必需脂肪酸、磷脂和丰富的钙、磷等矿物质。大豆分离蛋白消化利用率较高，氨基酸组成与牛奶蛋白质相近，在营养价值上可等同动物蛋白。在基因结构上也接近人体氨基酸，所以是高营养价值的植物蛋白质。
桑叶：为桑科桑属植物桑的叶；含有甾体及三萜类化合物如牛膝甾酮、蜕皮甾酮、豆甾酮等，黄酮及其苷类如芸香苷、槲皮素等，香豆素及其苷类如香柑内酯、伞形花内酯等，挥发油如乙酸、丙酸、丁酸等，氨基酸及肽类如谷氨酸、天冬氨酸、丙氨酸等，生物碱如腺嘌呤、胆碱等，有机酸及其化合物如绿原酸、棕榈酸等；桑叶性味苦、甘、寒，归肺、肝经；能疏散风热、清肺润燥、清肝明目；主治风热感冒、风温初起、发热头痛、汗出恶风、咳嗽胸痛，或肺燥干咳无痰、咽干口渴，风热及肝阳上扰、目赤肿痛等；现代药理学证明桑叶具有降血糖、抗炎、增加免疫功能、抗凝、抗菌等功效。
沙棘:有效调节胃肠功能；保肝护肝，防止肝硬化；心脑血管疾病防治；预防肿瘤、癌症；提高人体免疫力；止咳平喘 利肺化痰；打通微循环疏通血管；美容养颜 淡化黄褐斑。现代医学研究，沙棘可降低胆固醇，缓解心绞痛发作，还有防治冠状动脉粥样硬化性心脏病的作用。
山药：健脾益胃、助消化，山药含有淀粉酶、多酚氧化酶等物质，有利于脾胃消化吸收功能，是一味平补脾胃的药食两用之品。不论脾阳亏或胃阴虚，皆可食用；临床上常与胃肠饮同用治脾胃虚弱、食少体倦、泄泻等病症；滋肾益精，山药含有多种营养素，有强健机体，滋肾益精的作用。山药含有大量的黏液蛋白、维生素及微量元素，能有效阻止血脂在血管壁的沉淀，预防心血疾病，取得益志安神、延年益寿的功效。
桑葚：味甘性寒，人心肝、肾经，有滋阴补血作用，并能治阴虚津少、失眠等。古典中医文献记载：利五脏关节，通血气，安魂镇神，降压消渴，令人聪目，变白不老，解中酒毒等功效。现代医学临床证明：桑葚有很好的滋补心、肝、肾，及养血祛风的功效。对降脂和减轻神经衰弱、动脉硬化、性功能衰弱、耳聋眼花、须发早白、内热消渴、血虚便秘、风湿关节疼痛均有显著疗效。美国约翰·佩珠托领导的研究小组的实验发现，桑树含有抗肿瘤物质白藜芦醇，有抗癌作用。药理研究表明：桑葚入胃能补充胃液的缺乏，促进胃液的消化，人肠能促进肠液分泌，增进胃肠蠕动，因而有补益强壮之功。
甜叶菊：具有降血糖、降血压、保护肾脏、抗微生物等作用。
优选的，所述膳食纤维包括纤维素和菊粉。
纤维素具有吸附大量水分，增加粪便量，促进肠蠕动，加快粪便的排泄，使致癌物质在肠道内的停留时间缩短，对肠道的不良刺激减少的作用，从而可以预防肠癌发生。
菊粉为天然的水溶性膳食纤维，几乎不能被胃酸水解和消化，但能够被有益微生物利用，从而改善肠道环境，此外，摄入菊粉后能增强胃肠道蠕动，提高肠胃功能，增加消化和食欲，提高机体免疫力。
在本发明中菊粉还能够作为载体与益生菌相结合，在益生菌经过胃肠道时，能够促进益生菌自身代谢以便不同程度的修复人体消化液对菌株造成的损坏，能够减少益生菌经过胃肠道时的损失，提高存活率；菊粉能够被益生菌在肠道中直接利用，促进益生菌的增值，建立利于益生菌生长的环境条件，能够促进益生菌迅速定植肠道，更好的维持或回复肠道健康，执行抗炎和调节机体免疫活性。
优选的，所述纤维素30份、菊份3份。
优选的，所述益生菌包括植物乳杆菌、嗜酸乳杆菌和乳双岐杆菌。
研究表明，通过上述特定益生菌的选择，能够避免菌种间产生拮抗作用，提高各菌种的协同作用，进而提高固体饮料中的活菌量；此外，通过植物乳杆菌、嗜酸乳杆菌等分泌胞外多糖，能够提高肠道表皮细胞对益生菌产生亲和性，促进整体益生菌的肠道定植。
另外，各个菌种之间能够相互促进，更好的调节肠胃，促进肠道蠕动，缓解便秘腹泻，降低血清胆固醇，减轻乳糖耐受不良，积聚蛋白水解酶，调节营养吸收，调节机体免疫功能。
优选的，所述植物乳杆菌11份、嗜酸乳杆菌11份和乳双岐杆菌11份。
上述保健型固体饮料的制备方法：按照上述重量份数取各组分，然后过筛，即得。
本发明的有益效果：本发明具有改善肠道、提高人体免疫力、降血糖等保健的功效。同时，本发明还具有质量显著减轻，体积显著变小，携带方便，风味好，速溶性好，易于保持卫生，包装简易，运输方便及冲饮方便的优点。
具体实施方式
下面结合实施例对本发明作进一步的说明。
实施例1：本实施例的保健型固体饮料，包括由以下重量份数的组分：纤维素30份、菊粉3份、植物乳杆菌11份、嗜酸乳杆菌11份和乳双岐杆菌11份、大豆分离蛋白10份、桑叶粉10份、沙棘粉5份、山药粉5份、桑葚粉3份、甜叶菊粉1份。
本实施例的保健型固体饮料的制备方法：按照上述重量份数取各组分，然后过筛，即得。
实施例2：本实施例的保健型固体饮料，包括由以下重量的组分：纤维素3份、菊粉30份、植物乳杆菌11份、嗜酸乳杆菌11份和乳双岐杆菌11份、大豆分离蛋白10份、桑叶粉10份、沙棘粉5份、山药粉5份、桑葚粉3份、甜叶菊粉1份。
本实施例的制备方法同实施例1。
实施例3：本实施例的保健型固体饮料，包括由以下重量的组分：纤维素33份、植物乳杆菌11份、嗜酸乳杆菌11份和乳双岐杆菌11份、大豆分离蛋白10份、桑叶粉10份、沙棘粉5份、山药粉5份、桑葚粉3份、甜叶菊粉1份。
本实施例的制备方法同实施例1。
实施例4：本实施例的保健型固体饮料，包括由以下重量的组分：菊粉33份、植物乳杆菌11份、嗜酸乳杆菌11份和乳双岐杆菌11份、大豆分离蛋白10份、桑叶粉10份、沙棘粉5份、山药粉5份、桑葚粉3份、甜叶菊粉1份。
本实施例的制备方法同实施例1。
实施例5：本实施例的保健型固体饮料，包括由以下重量的组分：纤维素30份、菊粉3份、植物乳杆菌33份、大豆分离蛋白10份、桑叶粉10份、沙棘粉5份、山药粉5份、桑葚粉3份、甜叶菊粉1份。
本实施例的制备方法同实施例1。
实施例6：本实施例的保健型固体饮料，包括由以下重量的组分：纤维素30份、菊粉3份、嗜酸乳杆菌33份、大豆分离蛋白10份、桑叶粉10份、沙棘粉5份、山药粉5份、桑葚粉3份、甜叶菊粉1份。
本实施例的制备方法同实施例1。
实施例7：本实施例的保健型固体饮料，包括由以下重量的组分：纤维素30份、菊粉3份、乳双岐杆菌33份、大豆分离蛋白10份、桑叶粉10份、沙棘粉5份、山药粉5份、桑葚粉3份、甜叶菊粉1份。
本实施例的制备方法同实施例1。
实施例8：本实施例的保健型固体饮料，包括由以下重量的组分：纤维素30份、菊粉5份、植物乳杆菌8份、嗜酸乳杆菌12份、乳双岐杆菌13份、大豆分离蛋白10份、桑叶粉10份、沙棘粉5份、山药粉5份、桑葚粉3份、甜叶菊粉1份。
实施例9：本实施例的保健型固体饮料，包括由以下重量的组分：纤维素30份、菊粉3份、植物乳杆菌12份、嗜酸乳杆菌13份、乳双岐杆菌8份、大豆分离蛋白10份、桑叶粉10份、沙棘粉5份、山药粉5份、桑葚粉3份、甜叶菊粉1份。
本实施例的制备方法同实施例1。
实施例10：本实施例的保健型固体饮料，包括由以下重量的组分：纤维素30份、菊粉3份、植物乳杆菌13份、嗜酸乳杆菌8份、乳双岐杆菌12、大豆分离蛋白10份、桑叶粉10份、沙棘粉5份、山药粉5份、桑葚粉3份、甜叶菊粉1份。
本实施例的制备方法同实施例1。
需要说明的是：本文中的桑叶粉、沙棘粉、山药粉、桑葚粉、甜叶菊粉均由其自身植物粉碎而得到。
本发明的降血糖的固体饮料的使用方法为：每天早上5克上述的保健型固体饮料，用250毫升温开水搅拌均匀后服用，一个月为一疗程。
典型应用1
黄某某，男，45岁，检测服用者的空腹血糖值。服用上述实施例1制备的保健型固体饮料，每天早上取5克上述的保健型固体饮料，用250毫升温开水搅拌均匀后服用，坚持一个月后，再次检测服用者的空腹血糖值，服用前后，服用者的空腹血糖值从16mmol/L降到8mmol/L，服用者的空腹血糖值明显降低，继续服用一疗程，服用者的空腹血糖值可以稳定在6mmol/L左右，且无明显波动。
典型应用2
刘某，男，38岁，检测服用者的空腹血糖值。服用上述实施例1制备的保健型固体饮料，每天早上取5克上述的保健型固体饮料，用250毫升温开水搅拌均匀后服用，坚持一个月后，再次检测服用者的空腹血糖值，服用前后，服用者的空腹血糖值从13mmol/L降到7mmol/L，服用者的空腹血糖值明显降低，继续服用一疗程，服用者的空腹血糖值可以稳定在5mmol/L左右，且无明显波动。
典型应用3
王某某，女，40岁，检测服用者的空腹血糖值。服用上述实施例1制备的保健型固体饮料，每天早上取5克上述的保健型固体饮料，用250毫升温开水搅拌均匀后服用，坚持一个月后，再次检测服用者的空腹血糖值，服用前后，服用者的空腹血糖值从12mmol/ L降到8mmol/L，服用者的空腹血糖值明显降低，继续服用一疗程，服用者的空腹血糖值可以稳定在6mmol/L左右，且无明显波动。
Claims (6)
1.一种保健型固体饮料，其特征在于：包括以下重量份数的组分：膳食纤维33份、益生菌33份、大豆分离蛋白10份、桑叶粉10份、沙棘粉5份、山药粉5份、桑葚粉3份、甜叶菊粉1份。
2.根据权要求1所述的保健型固体饮料，其特征在于：所述膳食纤维包括纤维素和菊粉。
3.根据权利要求2所述的保健型固体饮料，其特征在于：所述纤维素30份、菊粉3份。
4.根据权利要求1或2或3所述的保健型固体饮料，其特征在于：所述益生菌包括植物乳杆菌、嗜酸乳杆菌和乳双岐杆菌。
5.根据权利要求4所述的保健型固体饮料，其特征在于：所述植物乳杆菌11份、嗜酸乳杆菌11份和乳双岐杆菌11份。
6.一种如权利要求 1-5任一项所述的保健型固体饮料的制备方法，其特征在于：按照上述重量份数取各组分，混合均匀，然后过筛，即得。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010144083.7A CN111084317A (zh) | 2020-03-04 | 2020-03-04 | 一种保健型固体饮料及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010144083.7A CN111084317A (zh) | 2020-03-04 | 2020-03-04 | 一种保健型固体饮料及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111084317A true CN111084317A (zh) | 2020-05-01 |
Family
ID=70400311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010144083.7A Pending CN111084317A (zh) | 2020-03-04 | 2020-03-04 | 一种保健型固体饮料及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111084317A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112841492A (zh) * | 2021-01-29 | 2021-05-28 | 拓丰粉体技术（昆山）有限公司 | 一种利尿止痛的植物固体饮料及其制备方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106174585A (zh) * | 2016-06-30 | 2016-12-07 | 山东凤凰生物有限公司 | 降血糖的组合物及降血糖的复合益生菌特膳食品 |
| CN107594284A (zh) * | 2017-10-23 | 2018-01-19 | 南京邦康生物技术有限公司 | 一种含有益生元和益生菌的固体饮料及其制备方法 |
| CN110024932A (zh) * | 2019-04-29 | 2019-07-19 | 哈尔滨求真生物科技有限公司 | 一种用于减肥、改善腹泻、调整菌群的黑木耳提取物固体饮料配方及其制备方法 |
| CN110200186A (zh) * | 2019-07-15 | 2019-09-06 | 无限极（中国）有限公司 | 一种益生菌固体饮料及其制备方法 |
-
2020
- 2020-03-04 CN CN202010144083.7A patent/CN111084317A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106174585A (zh) * | 2016-06-30 | 2016-12-07 | 山东凤凰生物有限公司 | 降血糖的组合物及降血糖的复合益生菌特膳食品 |
| CN107594284A (zh) * | 2017-10-23 | 2018-01-19 | 南京邦康生物技术有限公司 | 一种含有益生元和益生菌的固体饮料及其制备方法 |
| CN110024932A (zh) * | 2019-04-29 | 2019-07-19 | 哈尔滨求真生物科技有限公司 | 一种用于减肥、改善腹泻、调整菌群的黑木耳提取物固体饮料配方及其制备方法 |
| CN110200186A (zh) * | 2019-07-15 | 2019-09-06 | 无限极（中国）有限公司 | 一种益生菌固体饮料及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 高莉莉主编: "《家庭药食两用中药速查手册》", 31 October 2013, 中国医药科技出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112841492A (zh) * | 2021-01-29 | 2021-05-28 | 拓丰粉体技术（昆山）有限公司 | 一种利尿止痛的植物固体饮料及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110338402A (zh) | 一种复合益生菌粉及其制备方法 | |
| US9950024B2 (en) | Traditional Chinese medicine composition and the use thereof | |
| CN104855845A (zh) | 一种纳豆营养健康食品 | |
| CN104605353A (zh) | 适用于手术后肿瘤患者食用的配方食品及其制备方法 | |
| CN105768070A (zh) | 一种调理肠胃的功能性营养食品 | |
| KR100716123B1 (ko) | 마 또는 산약의 유산 발효액을 함유하는 변비 및 비만의예방 및 개선용 식품 조성물 | |
| CN106993788A (zh) | 全天然蜂王浆含片及其制备方法 | |
| CN109566760A (zh) | 一种具有溶栓作用的植物蛋白固体饮料及其制备方法 | |
| CN108936628A (zh) | 一种脑卒中患者食用的特定全营养配方食品及其制备方法 | |
| CN110692884A (zh) | 一种辅助降四高的益生菌保健饮料 | |
| KR100707707B1 (ko) | 마 또는 산약의 유산 발효액을 함유하는 변비 예방 및개선용 건강기능식품 | |
| CN104479964A (zh) | 一种黄秋葵、菌、藻保健酒及其制备方法 | |
| CN111374312A (zh) | 一种补充全面营养且易吸收的健康食品 | |
| CN101755878B (zh) | 一种含有苦瓜山楂决明子的减肥蛋糕的制备方法 | |
| JP2000166467A (ja) | 乳発酵産物及びハーブ類を含有してなる健康食品 | |
| CN111084317A (zh) | 一种保健型固体饮料及其制备方法 | |
| KR20110118911A (ko) | 한약재를 이용한 유산균 곡물 발효 추출물 및 이의 제조방법 | |
| CN109090391A (zh) | 一种具有高抗氧化活性的大豆多肽饮料及其制备方法 | |
| CN104186937A (zh) | 鱼出血病防治饲料 | |
| CN114947138A (zh) | 一种预防与改善钙缺乏病的乳钙组合物、其制法及应用 | |
| CN107712875A (zh) | 黑藜麦减肥代餐 | |
| CN1788578A (zh) | 一种微米松花魔芋露减肥降糖酸豆奶制备方法 | |
| JP3935490B2 (ja) | 豆乳ケフィア及びその製造方法 | |
| CN113749152A (zh) | 一种健康养生强身饮品及其制备方法 | |
| CN115702654A (zh) | 辅助降血糖的中老年调制羊奶粉及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200501 |